ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
"Biotechnologia Acta" V. 9, No 4, 2016
https://doi.org/10.15407/biotech9.04.007
Р. 7-13, Bibliography 48, English
Universal Decimal Classification: 604.4.665.371
THE CURRENT APPROACHES TO ZIKA VIRUS VACCINATION
F. Can 1, P. M. Pelin 1, A. Karahan 2, Z. Mustafaeva 1, B. Mamedov 3
1 Y?ld?z Technical University, Istanbul, Turkey
2 ?sk?dar University, Istanbul, Turkey
3 Azerbaijan Polymer Materials Institute of theNational Academy of Sciences of Azerbaijan, Sumgay?t
The aim of the review was to emphasize the importance of producing new generation high standardized synthetic peptide Zika vaccines which induce both humoral and cellular immunity and eliminate side effects of traditional vaccines. The information was done about Zika virus that is an artropod-born virus, member of the genus Flavivirus in the family Flaviviridae. Zika virus has caused outbreaks in many countries the conditions in adults such as Guillain–Barre syndrome by the dramatically increasing number of cases. According to announcement by World Health Organization, 4 million people could be infected with Zika virus in Americas.
The importance of the development of peptide vaccines against the virus Zika of the new generation, which are the most promising direction of the prevention and treatment of viral infection has emphasized.
Key words: Zika virus, peptide vaccines.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2016
{accordion title="References" open="false"}
1. ICTV. International Comitee on Taxonomy of viruses. Virus taxonomy: 2015 Release, Available online at: http://www.ictvonline.org/virustaxonomy.asp [accesed July 31, 2016].
2. World Health Organization, Zika Factsheets (June 2016), Available online at: http://www.who.int/mediacentre/factsheets/zika/en/, [accesed July 31, 2016].
3. Centers for Disease Control and Prevention, About Zika Virus Disase (July 2016) Available online at: http://www.cdc.gov/zika/about/overview.html, [accesed July 31, 2016].
4. Duffy M. R., Chen T., Hancock W. T., Powers A. M., Kool J. L., Lanciotti R. S., Pretrick M., Marfel M., Holzbauer S., Dubray C., Guillaumot L., Griggs A., Bel M., Lambert A. J., Laven J., Kosoy O., Panella A., Biggerstaff B. J., Fischer M., Hayes E. B. Zika virus outbreak on Yap island, Federated States of Micronesia. New Engl. J. Med. 2009, N 360, P. 2536?2543. https://doi.org/10.1056/NEJMoa0805715
5. World Health Organization, Zika Situation Report (June 2016), Available at: http://www.who.int/emergencies/zika-virus/situation-report/9-june-2016/en/ [accesed July 25, 2016].
6. Mlakar J., Korva M., Tul N., Popovi? M., Polj?ak-Prijatelj M., Kolenc M., Resman Rus K., Vesnaver Vipotnik T., Fabjan Vodu?ek V., Vizjak A. Zika Virus Associated with Microcephaly. New Engl. J. Med. 2016, N 374, P. 951?958. https://doi.org/10.1056/NEJMoa1600651
7. Brasil P., Sequeira P. C., D’Avila Freitas A., Einsfeld Zogbi H., Amaral Calvet G., Valls de Souza R., Machado Siqueira A., Lima de Mendonca M. C., Ribeiro Nogueira R. M., Bispo de Filippis A. M., Solomon T. Guillain-Barre syndrome associated with Zika virus infection (Case Report). Lancet. 2016, N 387, P. 1482. https://doi.org/10.1016/S0140-6736(16)30058-7
8. International Nucleotide Sequence Database Collaboration, NCBI Gen Bank, Available at: http://www.ncbi.nlm.nih.gov/nuccore/?term=zika, [accessed August 6, 2016].
9. Kuno G., Chang G. J. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch. Virol. 2007, 152 (4), 687?696. https://doi.org/10.1007/s00705-006-0903-z
10. Sirohi D., Chen Z., Sun L., Klose T., Pierson T. C., Rossmann M. G., Kuhn R. J. The 3.8 ? resolution cryo-EM structure of Zika virus. Science. 2016, 352 (6284), 467?470. https://doi.org/10.1126/science.aaf5316
11. Diallo D., Sall A. A., Diagne C. T., Faye O., Faye O., Ba Y., Hanley K. A., Buenemann M., Weaver S. C., Diallo M. Zika Virus Emergence in Mosquitoes in Southeastern Senegal, 2011. PLoS ONE. 2014, 9 (10), e109442. https://doi.org/10.1371/journal.pone.0109442
12. Kuno G., Chang G. J., Tsuchiya K. R., Karabatsos N., Cropp C. B. Phylogeny of the Genus. Flavivirus. J. Virol. 1998, 72 (1), 73–83.
13. Besnard M., Last?re S., Teissier A., Cao-Lormeau V. M., Musso D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill. 2014, 19 (13), pii=20751. Available online at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20751 [accessed 10 October 2016] https://doi.org/10.2807/1560-7917.ES2014.19.13.20751
14. Brasil P., Pereira J. P., Gabaglia C. R., Damasceno L., Wakimoto M., Ribeiro Nogueira R. M., Carvalho de Sequeira P., Andr? Machado Siqueira M. D., Liege M. Abreu de Carvalho M. D., Denise Cotrim da Cunha M. D., Guilherme A. Calvet M. D., Elizabeth S. Neves M. D., Maria E. Moreira M. D., Rodrigues Bai?o A. E., Nassar de Carvalho P. R., Janzen C., Valderramos S. G., Cherry J. D., Bispo de Filippis A. M., Nielsen-Saines K. Zika Virus Infection in Pregnant Women in Rio de Janeiro ? Preliminary Report. New Engl. J. Med. 2016. doi: 10.1056/NEJMoa1602412. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1602412 [accessed 16 October 2016]. https://doi.org/10.1056/NEJMoa1602412
15. Petersen L. R., Jamieson M. D., Powers A. M., Honein M. A. Zika Virus, New Engl. J. Med. 2016, N 374, P. 1552?1563. https://doi.org/10.1056/NEJMra1602113
16. Bearcroft W. G. Zika virus infection experimentally induced in a human volunteer. Trans. R. Soc. Trop. Med. Hyg. 1956, V. 50, P. 442?448. https://doi.org/10.1016/0035-9203(56)90090-6
17. Ginier M., Neumayr A., G?nther S., Schmidt-Chanasit J., Blum J. Zika without symptoms in returning travellers, what are the implications. Trav. Med. Infect. Dis. 2016, 14 (1), 16?20. https://doi.org/10.1016/j.tmaid.2016.01.012
18. Rasmussen S. A., Jamieson D. J., Honein M. A., Petersen L. R. Zika Virus and Birth Defects ? Reviewing the Evidence for Causality. New Engl. J. Med. 19 May, 2016, N 374, P. 1981?1987. https://doi.org/10.1056/NEJMsr1604338
19. Paploski I. A. D., Prates A. P. P. B., Cardoso C. W., Kikuti M., Silva M. M. O., Waller L. A., Reis M. G. Time lags between exanthematous illness attributed to Zika virus, Guillain-Barr? syndrome, and microcephaly, Salvador, Brazil. Emerg. Infect. Dis. 2016, 22 (8), 1438?1444. http://dx.doi.org/10.3201/eid2208. 160496.
20. Science News, Virus spread by mosquitoes linked to rare birth defect Available at: https://www.sciencenews.org/article/virus-spread-mosquitoes-linked-rare-birth-defect [accesed October 08, 2016].
21. Centers for Disease Control and Prevention, About Zika Virus Disase, July 25, 2016. Available at: http://www.cdc.gov/ncbddd/birthdefects/microcephaly.html. [accesed August 25, 2016].
22. Fiorentino D. G., Montero F. J. The Zika Virus and Pregnancy. Curr. Obstet. Gynecol. Rep. 2016, V. 5, P. 234. https://doi.org/10.1007/s13669-016-0171-1
23. Kleber de Oliveira W., Cortez-Escalante J., De Oliveira W. T., Ikeda do Carmo G. M., Maierovitch Pessanha Henriques C., Evelim Coelho G., Vin?cius Ara?jo de Fran? G. Increase in Reported Prevalence of Microcephaly in Infants Born to Women Living in Areas with Confirmed Zika Virus Transmission During the First Trimester of Pregnancy ? Brazil, 2015. MMWR Morb. Mortal Weekly Rep. 2016, V. 65, P. 242–247.https://doi.org/10.15585/mmwr.mm6509e2
24. Musso D., Gublerb D. J. Zika Virus. Clin. Microbiol. Rev. 2016, 29 (3) 487?524. https://doi.org/10.1128/CMR.00072-15
25. Lanciotti R. S., Kosoy O. L., Laven J. J., Velez J. O., Lambert A. J., Johnson A. J., Stanfield S. M., Duffy M. R. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 2008, 14 (8), 1232?1239. https://doi.org/10.3201/eid1408.080287
26. Faye O., Faye O., Diallo D., Diallo M., Weidmann M., Sall A. A. Quantitative real-time PCR detection of Zika virus and evaluation with field-caught Mosquitoes. Virol. J. 2013, V. 10, P. 311. https://doi.org/10.1186/1743-422X-10-311
27. Faye O., Faye O., Dupressoir A., Weidmann M., Ndiaye M., Alpha Sall A., One-step RT-PCR for detection of Zika virus. J. Clin. Virol. 2008, 43 (1), 96?101. https://doi.org/10.1016/j.jcv.2008.05.005
28. Corman V. M., Rasche A., Baronti C., Aldabbagh S., Cadar D., Reusken C. B. E. M., Pas S. D., Goorhuis A., Schinkel J., Molenkamp R., Kuemmerer B. M., Bleicker T., Br?nink S., Eschbach Bludau M., Eis-H?binger A. M., Koopmans M. P., Schmidt Chanasit J., Grobusch M. P., de Lamballerie X., Drostena C., Drexlera J. F. Clinical comparison, standardization and optimization of Zika virus molecular detection [Submitted]. Bull. World Health Organ E-pub: 19 Apr 2016. https://doi.org/10.2471/BLT.16.175950
29. Pardee K., Green A. A., Takahashi M. K., Braff D., Lambert G., Lee J. W., Ferrante T., Ma D., Donghia N., Fan M., Daringer N. M., Bosch I., Dudley D. M., O'Connor D. H., Gehrke L., Collins J. J. Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components Pardee. Cell. 2016, 165 (5), 1255–1266. https://doi.org/10.1016/j.cell.2016.04.059
30. Shan C., Xie X., Barrett A. D. T, Garcia-Blanco M. A., Tesh R. B., Fernando da Costa Vasconcelos P., Vasilakis N., Weaver S. C., Shi P. Y. Zika Virus: Diagnosis, Therapeutics, and Vaccine. ACS Infect. Dis. 2016, V. 2, 170?172. https://doi.org/10.1021/acsinfecdis.6b00030
31. Barba-Spaeth G., Dejnirattisai W., Rouvinski A., Vaney M. C., Medits I., Sharma A., Simon-Lori?re E., Sakuntabhai A., Cao-Lormeau V. M., Haouz A., England P., Stiasny K., Mongkolsapaya J., Heinz F. X., Screaton G. R., Rey F. A. Structural basis of potent Zika – dengue virus antibody cross-neutralization. Nature. 2016, N 536, P. 48–53. https://doi.org/10.1038/nature18938
32. Paul L. M., Carlin E. R., Jenkins M. M., Tan A. L., Barcellona C. M., Nicholson C. O., Trautmann L., Michael S. F., Isern S. Dengue Virus Antibodies Enhance Zika Virus Infection. bioRxiv, preprint. https://doi.org/10.1038/ni.3515
33. Dejnirattisai W., Supasa P., Wongwiwat W., Rouvinski A., Barba-Spaeth G., Duangchinda T., Sakuntabhai A., Cao-Lormeau V. M., Malasit P., Rey F. A., Mongkolsapaya J., Screaton G. R. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat. Immunol. 2016, V. 17, P. 1102–1108. doi: 10.1038/ni.3515.
34. Li C., Xu D., Ye Q., Hong S., Jiang Y., Liu X., Zhang N., Shi L., Qin C. F., Xu Z. Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice. Cell Stem. Cell. 2016, 19 (1), 120?126. doi: 10.1016/j.stem. 2016.04.017.
35. Larocca R. A., Abbink P., Peron J. P. S., de A. Zanotto P. M., Iampietro M. J., Badamchi-Zadeh A., Boyd M., Ng’ang’a D., Kirilova M., Nityanandam R., Mercado N. B., Li Z., Moseley E. T., Bricault C. A., Borducchi E. N., Giglio P. B., Jetton D., Neubauer G., Nkolola J. B., Maxfield L. F., De La Barrera D. A., Jarman R. G., Eckels K. H., Michael N. L., Thomas S. J., Barouch D. H. Vaccine protection against Zika virus from Brazil. Nature. 2016, N 536, P. 474–478. https://doi.org/10.1038/nature18952
36. Levine M., Sztein M. B. Vaccine development strategies for improving immunization: the role of modern immunology. Nat. Immunol. 2004, 5 (5), 460?464. https://doi.org/10.1038/ni0504-460
37. Englund J. A., Karron R. A., Cunningham C. K., Larussa P., Melvin A., Yogev R., Handelsman E., Siberry G. K., Thumar B., Schappell E., Bull C. V., Chu H. Y., Schaap-Nutt A., Buchholz U., Collins P. L., Schmidt A. C. International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1096 Study Group., Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children. Vaccine. 2013, 31 (48), 5706–5712. http://dx.doi.org/ 10.1016/j.vaccine.2013.09.046. https://doi.org/10.1016/j.vaccine.2013.09.046
38. Liljeqvist S., Stahl S. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J. Biotechnol. 1999, 73 (1), 1–33. https://doi.org/10.1016/S0168-1656(99)00107-8
39. Alexandr A. Moisa, Ekaterina F. Kolesanova (2012). Synthetic Peptide Vaccines, Insight and Control of Infectious Disease in Global Scenario, Dr. Roy Priti (Ed.). InTech. doi: 10.5772/33496. Available from: http://www.intechopen.com/ books/insight-and-control-of-infectious-disease-in-global-scenario/synthetic-peptide-vaccines. https://doi.org/10.5772/33496
40. Skwarczynski M., Toth I. Peptide-Based Subunit Nanovaccines. Curr. Drug Deliv. 2011, 8 (3), 282?289. https://doi.org/10.2174/156720111795256192
41. Shawan M. M. A. K., Mahmud H. A., Hasan M., Parvin A., Rahman N., Rahman S. M. B., In Silico. Modelling and Immunoinformatics Probing Disclose the Epitope Based PeptideVaccine Against Zika Virus Envelope Glycoprotein. Ind. J. Pharm. Biol. Res. 2014, 2 (4), 44?45.
42. Klavinskis L. S., Whitton J. L., Oldstone M. B. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J. Virol. 1989, 63 (10), 4311–4316.
43. K?l?n? Y. B., Akdeste Z. M., Ko? R. ?., Ba??rova M., Allahverdiyev A. Synthesis and characterization of antigenic influenza A M2e protein peptide-poly(acrylic) acid bioconjugate and determination of toxicity in vitro. Bioengineeringed. 2014, 5 (6), 357?362. https://doi.org/10.4161/21655979.2014.969131
44. Mansuroglu B., Mustafaeva Z. Characterization of water-soluble conjugates of polyacrylic acid and antigenic peptide of FMDV by size exclusion chromatography with quadruple detection. Mater Sci. Eng. C. 2012, V. 32, P. 112–118. https://doi.org/10.1016/j.msec.2011.10.004
45. Eroglu B. ?., Budama Kilinc Y., Mustafaeva Z. Bioconjugation of Hepatitis B antigenic peptide with polymeric carriers through various carbodiimide chemistry. Turk. J. Biochem. 2011, 36 (3), 222?229.
46. K?z?lbey K., Derman S., Mustafaeva Z. Poly (N-vinyl-2-pyrrolidone-co-acrylic acid): Comparing of “Traditional Heating” and “Microwave-Assisted” Free Radical Polymerization. J. Chem. Soc. Pak. 2013, 35 (4), 1191?1196.
47. Sevecen T. Biomolecule-polyelectrolyte conjugates (Masters dissertation) Yildiz Techical University, Bioengineering Department. advisor: Mustafaeva Z., Available from: Council of Higher Education Thesis Center Database. 2012, P. 1?201. (Thesis No: 316033).
48. Derman S., Mustafaeva Z. Particle size and zeta potential investigation of synthetic peptide-protein conjugates. Turkish J. Biotech. I. 2015, 40 (4), 282?289.
{/accordions}